These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 578667)

  • 1. Chevalier Jackson Lecture: In quest of the prevention of hyaline membrane disease.
    Avery ME
    Ann Otol Rhinol Laryngol; 1977; 86(5 Pt 1):573-6. PubMed ID: 578667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
    Liggins GC; Howie RN
    Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduced incidence of hyaline membrane disease in extremely premature infants following delay of delivery in mother with preterm labor: use of ritodrine and betamethasone.
    Kwong MS; Egan EA
    Pediatrics; 1986 Nov; 78(5):767-74. PubMed ID: 3532016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [First experiences with prenatal affection of infantile lung maturation by betamethason (author's transl)].
    Schwenzel W; Jung H; Lahmann H; Etzrodt A; Sticherling C; Korz K; Liedtke B; Chantraine H
    Z Geburtshilfe Perinatol; 1975 Feb; 179(1):45-52. PubMed ID: 1154818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevention of hyaline membrane disease: new concepts and approaches to therapy.
    Farrell PM; Kotas RV
    Adv Pediatr; 1976; 23():213-69. PubMed ID: 795280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antepartum prevention of respiratory distress syndrome (hyaline membrane disease).
    Sahu S
    J Iowa Med Soc; 1976 Dec; 66(12):481-3, 485-6. PubMed ID: 1036747
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surfactant and respiratory distress syndrome].
    Renovanz HD; von Seefeld H
    Prax Klin Pneumol; 1978 Jul; 32(7):443-66. PubMed ID: 28518
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucocorticoids and the respiratory distress syndrome in the newborn. A review of the literature].
    Gandibleux-Bergiers MF
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(5):625-37. PubMed ID: 6757311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in fetal lung maturity after maternal treatment with glucocorticoids].
    Gherzi R; Cottafavi M
    Minerva Ginecol; 1979 Nov; 31(11):815-20. PubMed ID: 263702
    [No Abstract]   [Full Text] [Related]  

  • 10. [Value of prenatal corticotherapy in the prevention of hyaline membrane disease in premature infants. Randomized prospective study].
    Fekih M; Chaieb A; Sboui H; Denguezli W; Hidar S; Khairi H
    Tunis Med; 2002 May; 80(5):260-5. PubMed ID: 12534029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory distress syndrome: the preventive use of glucocorticoids.
    Haller CC; King CR
    J Kans Med Soc; 1981 Mar; 82(3):98-106. PubMed ID: 6895085
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of the respiratory distress syndrome of the newborn. Value of antepartum treatment with glucocorticoids].
    Fargier P; Salle B; Baud ; Gagnaire JC; Arnaud P; Magnin P
    Nouv Presse Med; 1974 Jun; 3(25):1595-1597. PubMed ID: 4602249
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyaline membrane disease and surfactant protein, SAP-35, in diabetes in pregnancy.
    Nogee L; McMahan M; Whitsett JA
    Am J Perinatol; 1988 Oct; 5(4):374-7. PubMed ID: 3048286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Short-term respiratory outcome of late preterm newborn in a center of level III].
    Champion V; Durrmeyer X; Dassieu G
    Arch Pediatr; 2010 Jan; 17(1):19-25. PubMed ID: 19910172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antenatal glucocorticoid therapy for the prevention of respiratory distress syndrome in the premature infant.
    Block MF; Kling OR; Crosby WM
    Obstet Gynecol; 1977 Aug; 50(2):186-90. PubMed ID: 327364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevention of hyaline membrane disease by intraamniotic administration of thyroxine].
    Amato M; Sidiropoulos D; von Muralt G
    Pediatr Med Chir; 1984; 6(3):363-5. PubMed ID: 6533584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058
    [No Abstract]   [Full Text] [Related]  

  • 18. Hyaline membrane disease.
    Farrell PM; Avery ME
    Am Rev Respir Dis; 1975 May; 111(5):657-88. PubMed ID: 1093459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Induction of fetal lung maturation in the prevention of hyaline membrane disease: the connection with neonatal sepsis].
    Driul L; Furlan R; Macagno F; Pezzani I; Plaino L; Ianni A; Casarsa S; Zavarise D; Marchesoni D
    Minerva Ginecol; 2003 Feb; 55(1):37-42. PubMed ID: 12598841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceleration of fetal pulmonary maturity.
    Bishop EH
    Obstet Gynecol; 1981 Nov; 58(5 Suppl):48S-51S. PubMed ID: 7312228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.